195 related articles for article (PubMed ID: 35097154)
1. Trimethoprim-Sulfamethoxazole Versus Levofloxacin for
Sarzynski SH; Warner S; Sun J; Matsouaka R; Dekker JP; Babiker A; Li W; Lai YL; Danner RL; Fowler VG; Kadri SS
Open Forum Infect Dis; 2022 Feb; 9(2):ofab644. PubMed ID: 35097154
[TBL] [Abstract][Full Text] [Related]
2. Trimethoprim-sulfamethoxazole versus levofloxacin for the treatment of Stenotrophomonas maltophilia infections: A multicentre cohort study.
Almangour TA; Alkherb Z; Alruwaite S; Alsahli R; Alali H; Almohaizeie A; Almuhisen S; Alowais SA; Saleh KB; Fetyani L; Alnashmi F; Alghofaily A; Abouobaid NI; Binkhamis KM; Tawfik EA; Alsowaida YS
J Glob Antimicrob Resist; 2024 May; 38():42-48. PubMed ID: 38821443
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of Stenotrophomonas maltophilia infection treated with trimethoprim/sulfamethoxazole, minocycline, or fluoroquinolone monotherapy.
Junco SJ; Bowman MC; Turner RB
Int J Antimicrob Agents; 2021 Aug; 58(2):106367. PubMed ID: 34058337
[TBL] [Abstract][Full Text] [Related]
4. Association between minimum inhibitory concentration values and mortality risk in patients with
Sarzynski SH; Lawandi A; Warner S; Demirkale CY; Strich JR; Dekker JP; Babiker A; Li W; Kadri SS
JAC Antimicrob Resist; 2023 Apr; 5(2):dlad049. PubMed ID: 37124072
[TBL] [Abstract][Full Text] [Related]
5. The Activities of Antimicrobials Against
Boonmee P; Nasomsong W; Lorchirachoonkul N; Pungcharoenkijkul S; Juntanawiwat P; Chaemchaeng S; Santimaleeworagun W
Infect Drug Resist; 2023; 16():5173-5184. PubMed ID: 37581163
[TBL] [Abstract][Full Text] [Related]
6. Emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan.
Wu RX; Yu CM; Hsu ST; Wang CH
J Microbiol Immunol Infect; 2022 Feb; 55(1):107-113. PubMed ID: 33500210
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and Antibiotic Resistance of
Gajdács M; Urbán E
Health Serv Res Manag Epidemiol; 2019; 6():2333392819870774. PubMed ID: 31453265
[TBL] [Abstract][Full Text] [Related]
8. Appropriate antibiotic therapy is a predictor of outcome in patients with Stenotrophomonas maltophilia blood stream infection in the intensive care unit.
Lai JJ; Siu LK; Chang FY; Lin JC; Yu CM; Wu RX; Wang CH
J Microbiol Immunol Infect; 2023 Jun; 56(3):624-633. PubMed ID: 36948945
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Epidemiological Characteristics of Stenotrophomonas maltophilia Associated Lower Respiratory Tract Infections in Qatar: A Retrospective Study.
Nair AP; Sasi S; Al Maslamani M; Al-Khal A; Chacko K; Deshmukh A; Abukhattab M
Cureus; 2022 Mar; 14(3):e23263. PubMed ID: 35449666
[TBL] [Abstract][Full Text] [Related]
10. A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan.
Wu H; Wang JT; Shiau YR; Wang HY; Lauderdale TL; Chang SC;
J Microbiol Immunol Infect; 2012 Apr; 45(2):120-6. PubMed ID: 22154599
[TBL] [Abstract][Full Text] [Related]
11. Emerging importance of multidrug-resistant Stenotrophomonas maltophilia infections in neonatal intensive care unit in a tertiary center in Turkey.
Demirbuğa A; Akgün Karapınar DB; Yaşa B; Çoban A; Öngen B; Dede E; Mete Atasever N; Somer A; Hançerli Törün S
Pediatr Neonatol; 2024 Mar; 65(2):183-187. PubMed ID: 37919104
[TBL] [Abstract][Full Text] [Related]
12. Treatment, clinical outcomes, and predictors of mortality among a national cohort of hospitalized patients with Stenotrophomonas maltophilia infection.
Appaneal HJ; Lopes VV; LaPlante KL; Caffrey AR
Public Health; 2023 Jan; 214():73-80. PubMed ID: 36521275
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic Susceptibility and Minimum Inhibitory Concentration for
Ho MM; Sun MH; Wu WC; Lai CC; Yeh LK; Hwang YS; Hsiao CH; Chen KJ
Antibiotics (Basel); 2022 Oct; 11(11):. PubMed ID: 36358112
[TBL] [Abstract][Full Text] [Related]
14. Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia?
Cho SY; Kang CI; Kim J; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
Antimicrob Agents Chemother; 2014; 58(1):581-3. PubMed ID: 24126583
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological Trends and Resistance Associated with
Gajdács M; Urbán E
Diseases; 2019 May; 7(2):. PubMed ID: 31159258
[No Abstract] [Full Text] [Related]
16. The Burden of Bloodstream Infections due to
Cai B; Tillotson G; Benjumea D; Callahan P; Echols R
Open Forum Infect Dis; 2020 May; 7(5):ofaa141. PubMed ID: 32462047
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.
Hu LF; Gao LP; Ye Y; Chen X; Zhou XT; Yang HF; Liiu YY; Mei Q; Li JB
J Chemother; 2014 Oct; 26(5):282-6. PubMed ID: 24588423
[TBL] [Abstract][Full Text] [Related]
18. Global prevalence and distribution of antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia: A systematic review and meta-analysis.
Dadashi M; Hajikhani B; Nazarinejad N; Noorisepehr N; Yazdani S; Hashemi A; Hashemizadeh Z; Goudarzi M; Fatemeh S
J Glob Antimicrob Resist; 2023 Sep; 34():253-267. PubMed ID: 36906172
[TBL] [Abstract][Full Text] [Related]
19. Distribution of Class 1 Integrons, sul1 and sul2 Genes Among Clinical Isolates of Stenotrophomonas maltophilia from a Tertiary Care Hospital in North India.
Kaur P; Gautam V; Tewari R
Microb Drug Resist; 2015 Aug; 21(4):380-5. PubMed ID: 25781206
[TBL] [Abstract][Full Text] [Related]
20. Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients.
Wang CH; Yu CM; Hsu ST; Wu RX
J Hosp Infect; 2020 Jan; 104(1):46-52. PubMed ID: 31505224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
